1. Home
  2. LMT vs BMY Comparison

LMT vs BMY Comparison

Compare LMT & BMY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Lockheed Martin Corporation

LMT

Lockheed Martin Corporation

N/A

Current Price

$473.59

Market Cap

105.1B

Sector

Industrials

ML Signal

N/A

Logo Bristol-Myers Squibb Company

BMY

Bristol-Myers Squibb Company

N/A

Current Price

$53.78

Market Cap

95.0B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
LMT
BMY
Founded
1912
1887
Country
United States
United States
Employees
N/A
N/A
Industry
Military/Government/Technical
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
105.1B
95.0B
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
LMT
BMY
Price
$473.59
$53.78
Analyst Decision
Hold
Buy
Analyst Count
15
13
Target Price
$512.07
$56.31
AVG Volume (30 Days)
1.3M
15.5M
Earning Date
01-27-2026
02-05-2026
Dividend Yield
2.89%
4.65%
EPS Growth
N/A
N/A
EPS
17.88
2.97
Revenue
$73,349,000,000.00
$48,034,000,000.00
Revenue This Year
$6.01
$0.23
Revenue Next Year
$4.23
N/A
P/E Ratio
$26.68
$18.26
Revenue Growth
2.88
1.26
52 Week Low
$410.11
$42.52
52 Week High
$516.00
$63.33

Technical Indicators

Market Signals
Indicator
LMT
BMY
Relative Strength Index (RSI) 55.01 69.64
Support Level $455.88 $50.33
Resistance Level $484.77 $54.80
Average True Range (ATR) 9.41 1.18
MACD 3.68 0.29
Stochastic Oscillator 77.13 84.04

Price Performance

Historical Comparison
LMT
BMY

About LMT Lockheed Martin Corporation

Lockheed Martin is the world's largest defense contractor and has dominated the Western market for high-end fighter aircraft since it won the F-35 Joint Strike Fighter program in 2001. Aeronautics is Lockheed's largest segment, which derives upward of two-thirds of its revenue from the F-35. Lockheed's remaining segments are rotary and mission systems, mainly encompassing the Sikorsky helicopter business; missiles and fire control, which creates missiles and missile defense systems; and space systems, which produces satellites and receives equity income from the United Launch Alliance joint venture.

About BMY Bristol-Myers Squibb Company

Bristol-Myers Squibb discovers, develops, and markets drugs for various therapeutic areas, such as cardiovascular, cancer, and immune disorders. A key focus for Bristol is immuno-oncology, where the firm is a leader in drug development. Bristol derives close to 70% of total sales from the US, showing a higher dependence on the US market than most of its peer group.

Share on Social Networks: